Patent · US Expired

Mercaptoimidazoles as CCR2 receptor antagonists

US7511068B2 · kind B2 · utility

4Cited by

6References

12Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Guy Rosalia Eugeen Van Lommen · Berlaar, BE
Julien Georges Pierre-Olivier Doyon · Beerse, BE
Jean Pierre Frans Van Wauwe · Beerse, BE
Marina Cools · Retie, BE
Erwin Coesemans · Nijlen, BE

Key dates

Filing date	Jan 30, 2004
Grant date	Mar 31, 2009
Priority date	—
Expiry date	Sep 26, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula (I) having CCR2 receptor antagonistic properties, particularly anti-inflammatory properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.